NEW YORK (CBSNewYork) — This week, the Centers for Disease Control and Prevention released statistics on who’s most likely to die from COVID-19, while British doctors announced an important development that could save many lives.
CBS2’s Dr. Max Gomez has more in his latest Max Minute report.
Scientists at the University of Oxford announced Tuesday that a low-cost steroid could significantly reduce deaths for hospitalized patients.
The steroid dexamethasone reduced deaths by a third in patients on ventilators, while patients who were only receiving oxygen treatment saw a 20% reduction in mortality. There was no benefit from the drug in patients who did not need respiratory support.
- Resources, Hotlines, Unemployment & Covering Bills
- Remote Learning Tools For Parents Teaching At Home
- Ask Dr. Max Your Health Questions
- How Make Your Own DIY Face Mask
- How To Safely Remove Disposable Gloves
- Tips For Parents To Help Kids Cope
- Chopper 2 Over Empty NYC Streets, Landmarks
- Complete Coronavirus Coverage
Dexamethasone is the first drug proven to improve survival in COVID-19, according to a chief investigator. It is inexpensive, approved worldwide, and the survival benefit is clear and large enough that British doctors have already made it the standard of care for COVID-19 patients on oxygen.
There are disturbing numbers now in the U.S. While it has been known that people with underlying health conditions were most likely to become seriously ill from coronavirus, the CDC reports hospitalizations were six times higher and deaths 12 times higher among those with underlying conditions, especially cardiovascular disease, diabetes, and chronic lung conditions.
It’s not clear how dexamethasone works, but it is a powerful anti-inflammatory that could be tamping down the massive immune over-reaction in the lungs of COVID-19 patients. It may be even more effective when combined with an anti-viral drugs such as remdesivir.